Skip to main content
. 2014 Jan 2;10(4):977–981. doi: 10.4161/hv.27621

graphic file with name khvi-10-04-10927621-g001.jpg

Figure 1. Optimization of bladder cancer vaccination using intravesical immunostimulants. TAA, tumor-associated antigen; TLR, toll-like receptors; BCG, Bacillus Calmette-Guérin.